Table 4 The underlying diseases among the studied cases
From: The severity and atypical presentations of COVID-19 infection in pediatrics
| Studied variables | Number | (%) |
|---|---|---|
| No underlying diseases | 305 | 76.6% |
| Underlying diseases | 93 | 23.4% |
| • Epilepsy | 23 | 5.8% |
| • *ITP | 20 | 5.0% |
| • Chronic kidney disease | 20 | 5.0% |
| • Neurodegenerative disease | 7 | 1.8% |
| • Arnold Chiari syndrome | 7 | 1.8% |
| • Guillain barre syndrome | 6 | 1.5% |
| • *G6PD | 5 | 1.25% |
| • Beta thalassemia | 3 | 0.75% |
| • Dyskeratosis congenita | 2 | 0.5% |